Adequacy of Peripheral Blood Stem Cell Mobilization in Patients With Relapsed Lymphoma Treated With Bendamustine: A Pilot Project and a Proof of Concept Study
Phase of Trial: Phase 0
Latest Information Update: 12 Jan 2017
At a glance
- Drugs Bendamustine (Primary) ; Rituximab
- Indications Non-Hodgkin's lymphoma
- Focus Proof of concept; Therapeutic Use
- 12 Jan 2017 Status changed from active, no longer recruiting to completed.
- 31 Mar 2015 Planned End Date changed from 1 Jan 2015 to 1 Sep 2015, as reported by ClinicalTrials.gov.
- 05 Nov 2014 Planned End Date changed from 1 Sep 2014 to 1 Jan 2015 as reported by ClinicalTrials.gov.